Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ardhi, Rajeswari"'
Autor:
Sourav Patra, Rubel Chakravarty, Jitendra Bahadur, Apurav Guleria, Ardhi Rajeswari, K.V. Vimalnath, K.K. Kamaleshwaran, Debasis Sen, Sudipta Chakraborty
Publikováno v:
Materials Chemistry and Physics. 295:127115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5d1051ddbb31573ce90a05568485c29
https://doi.org/10.1016/j.matchemphys.2022.127115
https://doi.org/10.1016/j.matchemphys.2022.127115
Autor:
Rubel, Chakravarty, Priyalata, Shetty, K V Vimalnath, Nair, Ardhi, Rajeswari, K C, Jagadeesan, Haladhar Dev, Sarma, Venkatesh, Rangarajan, Rahul, Krishnatry, Sudipta, Chakraborty
Publikováno v:
Annals of nuclear medicine. 34(12)
Copper-64 is a useful theranostic radioisotope that is attracting renewed interest from the nuclear medicine community in the recent times. This study aims to demonstrate the utility of research reactors to produce clinical-gradeCopper-64 was produce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12d1dce1aaf2e65773e7651476f5a91a
https://pubmed.ncbi.nlm.nih.gov/33048309
https://pubmed.ncbi.nlm.nih.gov/33048309
Autor:
Rubel, Chakravarty, Ardhi, Rajeswari, Priyalata, Shetty, K C, Jagadeesan, Ramu, Ram, Sachin, Jadhav, Haladhar Dev, Sarma, Ashutosh, Dash, Sudipta, Chakraborty
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 165
Copper-64 is an excellent theranostic radiometal that is gaining renewed attention of the clinical community in the recent times. In order to meet the increasing demand of this radiometal, we have demonstrated the viability of its production via
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0def5f54ed815993a5701b238736d8ed
https://pubmed.ncbi.nlm.nih.gov/32745917
https://pubmed.ncbi.nlm.nih.gov/32745917
Autor:
Rubel, Chakravarty, Sudipta, Chakraborty, Haladhar Dev, Sarma, K V Vimalnath, Nair, Ardhi, Rajeswari, Ashutosh, Dash
Publikováno v:
Journal of labelled compoundsradiopharmaceuticals. 59(9)
Radiolabelled monoclonal antibodies (mAbs) are increasingly being utilized in cancer theranostics, which is a significant move toward tailored treatment for individual patients. Cetuximab is a recombinant, human-mouse chimeric IgG1 mAb that binds to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37b469c9c43cf7d4afdbd80248425e9f
https://pubmed.ncbi.nlm.nih.gov/27264196
https://pubmed.ncbi.nlm.nih.gov/27264196